Unusual gastric and pancreatic metastatic renal cell carcinoma presentation 10 years after surgery and immunotherapy: A case report and a review of literature  

作　　者：Chiara Riviello Ilaria Tanini Greta Cipriani Pietro Pantaleo Carlo Nozzoli Alberto Poma Viligiardi Riccardo Andrea Valeri 

机构地区：[1]Second Division of General and Vascular Surgery Careggi Hospital,Florence,Italy [2]Department of Internal Medicine Oncologic Day-Hospital University of Florence,Italy [3]Second Division of Internal Medicine Careggi Hospital,Florence,Italy

出　　处：《World Journal of Gastroenterology》2006年第32期5234-5236,共3页世界胃肠病学杂志（英文版）

摘　　要：Renal cell carcinoma （RCC） is the most common renal tumor, accounting for 2%-3% of all malignancies. Though RCC is known to spread hematogenously, isolated RCC metastasis to the stomach is a rare event. In this article, we describe the clinical course of a patient who developed a pancreatic recurrence of RCC and 1 year later a gastric recurrence of RCC treated 10 years ago with a resection and interleukin-2 （IL-2）. Accumulating evidence indicates that metastatic involvement of the pancreas and stomach should be suspected in any patient with a history of RCC who presents with gastrointestinal symptoms even 10 years after RCC resection and immunotherapy.肾的房间癌(RCC ) 是最普通的肾的肿瘤，为所有恶意的 2%-3% 的财务。尽管 RCC 被知道造血地传播，到胃的孤立的 RCC 转移是一个稀罕事件。在这篇文章，我们描述 RCC 的胃的复发 10 年以前与切除术和 interleukin-2 (IL-2 ) 对待的以后开发了 RCC 和 1 年的胰腺的复发的一个病人的临床的功课。积累的证据显示胰和胃的那变形参与应该与 RCC 的历史在任何病人被怀疑在 RCC 切除术和免疫疗法以后与胃肠的症状介绍甚至 10 年。

关 键 词：Renal cell carcinoma Stomach metastasis Interleukin-2 treatment 

分 类 号：R735[医药卫生—肿瘤] R737.11[医药卫生—临床医学]